Xinxiang Tuoxin Pharmaceutical Co.Ltd. Net Asset Quality Index
Xinxiang Tuoxin Pharmaceutical Co.Ltd. net asset quality index. Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Net Asset Quality Index of 89.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.65 Billion minus total liabilities of CN¥176.07 Million yields net assets of CN¥1.47 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2025)
Net asset quality index of Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2025. This chart shows how Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 89.3%, representing net assets of CN¥1.47 Billion against total assets of CN¥1.65 Billion CNY. See what is Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s book value for net asset value and shareholders' equity analysis.
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Net Asset Quality Index by Year (2019–2025)
Xinxiang Tuoxin Pharmaceutical Co.Ltd. net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Xinxiang Tuoxin Pharmaceutical Co.Ltd..
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.1% | CN¥1.48 Billion | CN¥1.67 Billion | CN¥181.12 Million | ▲ +0.8 pp |
| 2024 | 88.3% | CN¥1.55 Billion | CN¥1.76 Billion | CN¥205.72 Million | ▲ +1.1 pp |
| 2023 | 87.2% | CN¥1.60 Billion | CN¥1.84 Billion | CN¥235.72 Million | ▲ +12.5 pp |
| 2022 | 74.7% | CN¥1.38 Billion | CN¥1.84 Billion | CN¥466.89 Million | ▼ -4.1 pp |
| 2021 | 78.7% | CN¥1.10 Billion | CN¥1.39 Billion | CN¥296.35 Million | ▲ +26.9 pp |
| 2020 | 51.9% | CN¥490.87 Million | CN¥946.48 Million | CN¥455.61 Million | ▲ +0.1 pp |
| 2019 | 51.8% | CN¥383.11 Million | CN¥739.85 Million | CN¥356.74 Million | — |